Genpharmasec Ltd. - Research Center
531592 GENPHARMA Group (XT) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Mar ' 20 |
Sales |
13.82 |
12.89 |
14.20 |
13.12 |
8.19 |
Operating profit |
-0.02 |
-0.17 |
0.01 |
-0.53 |
0.50 |
Interest |
0.13 |
- |
- |
- |
- |
Gross profit |
0.12 |
-0.14 |
0.03 |
-0.46 |
0.76 |
EPS (Rs) |
- |
-0.01 |
0.01 |
-0.02 |
0.03 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Mar ' 20 |
Other income |
0.26 |
0.02 |
0.03 |
0.07 |
0.27 |
Stock adjustment |
-0.71 |
2.64 |
0.09 |
-2.29 |
-0.78 |
Raw material |
- |
- |
- |
- |
- |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
0.37 |
0.18 |
0.15 |
0.10 |
0.08 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
14.18 |
10.24 |
13.95 |
15.84 |
8.39 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.01 |
0.01 |
0.01 |
0.01 |
- |
Taxation |
0.08 |
- |
-0.23 |
- |
0.20 |
Net profit / loss |
0.03 |
-0.15 |
0.26 |
-0.47 |
0.56 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
27.69 |
27.69 |
27.69 |
27.69 |
21.69 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
-0.13 |
-1.28 |
0.05 |
-4.03 |
6.06 |
GPM (%) |
.84 |
-1.10 |
.24 |
-3.51 |
9.01 |
NPM (%) |
0.24 |
-1.16 |
1.83 |
-3.56 |
6.66 |